Compass Therapeutics

CMPXNASDAQ
$1.00
-0.2-16.67%
At Close: -
$1.04
0.044.00%
After Hours: 7:03 PM EDT
15 minutes delayed

Compass Therapeutics (NASDAQ:CMPX) Stock, Insider Trading Activity

Compass Therapeutics: Insider buying and selling updated today.

Insider Shares Owned
11.521M
Insider Percentage Owned
8.37%
Institutional Shares Held
15.966M
Institutional Percentage Held
11.6%
Mar 10, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER10K$3.37$33.70KBUY0.17%6.021873MMar 10View
Feb 27, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER20K$3.98$79.60KBUY0.33%6.011873MFeb 27View
Feb 15, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER20K$3.86$77.20KBUY0.33%5.991873MFeb 15View
Jan 31, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER20K$4.05$81.00KBUY0.37%5.471873MJan 31View
Jan 24, 2023Thomas J SchuetzCHIEF EXECUTIVE OFFICER20K$4.19$83.80KBUY0.37%5.451873MJan 24View
Nov 25, 2022Vered Bisker-LeibCHIEF OPERATING OFFICER-24.5K$4.23-$103.71KSELL-2.26%1.060414MNov 22 - Nov 25View
Nov 22, 2022Vered Bisker-LeibCHIEF OPERATING OFFICER-22.261K$4.36-$96.99KSELL-2.01%1.084914MNov 18 - Nov 21View
Nov 10, 2022ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Genesis GP LLCDIRECTOR402K$3.21$1.29MBUY2.19%18.791422MNov 08View
Nov 10, 2022Carl GordonDIRECTOR402K$3.21$1.29MBUY2.19%18.791422MNov 08View
Sep 28, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER10K$2.32$23.20KBUY0.18%5.431873MSep 28View
Sep 27, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15K$2.27$34.05KBUY0.28%5.421873MSep 26View
Sep 08, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15K$3.03$45.45KBUY0.28%5.406873MSep 07View
Sep 01, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15K$2.83$42.45KBUY0.28%5.391873MSep 01View
Aug 17, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15K$3.05$45.75KBUY0.28%5.376873MAug 17View
Aug 10, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15K$2.64$39.60KBUY0.28%5.361873MAug 10View
Aug 02, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER15K$2.58$38.70KBUY0.28%5.346873MAug 01View
Jun 21, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20K$2.80$56.00KBUY0.38%5.331873MJun 21View
Jun 17, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20K$2.34$46.80KBUY0.38%5.311873MJun 16View
Jun 13, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER30K$2.29$68.70KBUY0.57%5.291873MJun 13View
Jun 07, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER30K$2.83$84.90KBUY0.57%5.261873MJun 06View
Jun 01, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20K$3.03$60.60KBUY0.38%5.231873MJun 01View
May 26, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20K$3.04$60.80KBUY0.39%5.211873MMay 26View
May 24, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER18.355K$2.72$49.93KBUY0.35%5.191873MMay 23View
May 17, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER20.215K$2.47$49.93KBUY0.39%5.173518MMay 17View
May 13, 2022Carl Gordon Member of OrbiMed Advisors LLCDIRECTOR192.516K$2.18$420.48KBUY1.06%18.389422MMay 11 - May 13View
May 13, 2022ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Genesis GP LLCDIRECTOR192.516K$2.18$420.48KBUY1.06%18.389422MMay 11 - May 13View
May 10, 2022ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Genesis GP LLCDIRECTOR125.359K$1.57$197.25KBUY0.69%18.196906MMay 06 - May 10View
May 10, 2022Carl GordonDIRECTOR125.359K$1.57$197.25KBUY0.69%18.196906MMay 06 - May 10View
May 10, 2022Thomas J SchuetzCHIEF EXECUTIVE OFFICER27.836K$1.80$50.10KBUY0.54%5.153303MMay 10View
Nov 08, 2021Carl Gordon Member of OrbiMed Advisors LLCDIRECTOR5.357143M$3.50$18.75MBUY3.571428MNov 04View
Nov 08, 2021ORBIMED ADVISORS LLCOrbiMed Capital GP V LLCOrbiMed Genesis GP LLCDIRECTOR5.357143M$3.50$18.75MBUY3.571428MNov 04View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch